Capricor Therapeutics
CAPR
#5368
Rank
NZ$2.53 B
Marketcap
NZ$43.74
Share price
-2.61%
Change (1 day)
90.10%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -NZ$0.19 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -NZ$69.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$0.19 Billion159.57%
2024 -NZ$69.89 Million81.57%
2023 -NZ$38.49 Million-23.2%
2022 -NZ$50.12 Million44.93%
2021 -NZ$34.58 Million46.61%
2020 -NZ$23.59 Million78.71%
2019 -NZ$13.2 Million-49.7%
2018 -NZ$26.24 Million-724.78%
2017 NZ$4.19 M-112.93%
2016 -NZ$32.48 Million46.27%
2015 -NZ$22.21 Million106.82%
2014 -NZ$10.74 Million-48.41%
2013 -NZ$20.81 Million977.23%
2012 -NZ$1.94 Million-77.11%
2011 -NZ$8.44 Million-22.35%
2010 -NZ$10.87 Million-20.17%
2009 -NZ$13.62 Million-41.17%
2008 -NZ$23.15 Million41.05%
2007 -NZ$16.41 Million1098.87%
2006 -NZ$1.37 Million4101.55%
2005 -NZ$0.04 Million-0.97%
2004 -NZ$0.04 Million17.87%
2003 -NZ$0.03 Million3.66%
2002 -NZ$0.03 Million-30.11%
2001 -NZ$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.86 B-24,832.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.37 B-860.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.44 Billion 689.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.5 Billion 173.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$8.29 Million-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$16.39 Million-90.97%๐Ÿ‡บ๐Ÿ‡ธ USA